Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Astrocyte-derived CNTF switches mature RGCs to a regenerative state following inflammatory stimulation

next article
30.10.2007

Retinal ganglion cells (RGCs) normally fail to regenerate injured axons and undergo apoptosis soon after injury.

 

We have recently shown that lens injury (LI) or intravitreally applied zymosan allow RGCs to survive axotomy and regenerate axons in the injured optic nerve.


Activated macrophages and oncomodulin have been suggested to be the principal mediators of this phenomenon. However, several lines of evidence show that macrophage-derived factors alone cannot account for all the beneficial effects of intraocular inflammation.

We show here that LI or zymosan induce upregulation of ciliary neurotrophic factor (CNTF) in retinal astrocytes and release CNTF independent of macrophages and activate the transcription factor signal transducers and activators of transcription 3 (STAT3) in RGCs. Levels of CNTF expressed in retinal glia and STAT3 activation in RGC were correlated with the time course of RGCs switching to an active regenerative state.

Intravitreal injections of antibodies against CNTF or a Janus-kinase inhibitor compromised the beneficial effects of LI, whereas an antiserum against oncomodulin was ineffective. Like the action of CNTF, the effects of LI were potentiated by drugs that increase intracellular cAMP levels, resulting in strong axon regeneration in vivo.

These data indicate that astrocyte-derived CNTF is a major contributor to the neuroprotective and axon-growth-promoting effects of LI and zymosan. These findings could lead to the development of a therapeutic principle for promoting axon regeneration in the CNS as a whole.

Willi Baur | Source: Informationsdienst Wissenschaft
Further information: brain.oxfordjournals.org/cgi/content/abstract/awm257v1
www.uni-ulm.de/klinik/neurologie/fischer/Web-Site/Dietmar%20Fischer.html

next article

More articles from Health and Medicine:

nachricht Towards Improved Immunotherapy
01.12.2008 | Elsevier

nachricht First trial in patients with a potential treatment of the incurable ALS muscle disease
01.12.2008 | VIB, the Flanders Institute for Biotechnology

B2B Search

Product / Service
Company / Organisation

Latest News

Wilkins Ice Shelf under threat

01.12.2008 | Earth Sciences

A picture paints more than a petabyte of data

01.12.2008 | Physics and Astronomy

Sex life of killer fungus finally revealed

01.12.2008 | Life Sciences

Event News

Dublin to host Europe’s largest interdisciplinary science conference in 2012

28.11.2008 | Event News

ECREA Barcelona 2008

28.11.2008 | Event News

The Automobile – The Transition from Energy Guzzler to Power Supplier

20.11.2008 | Event News